Background and Purpose-Asymptomatic embolic signals (ES) detected using transcranial Doppler have been reported in patients with potential cerebral embolic sources. They may be useful in risk stratification and in assessing therapies. First, it is essential to show whether they predict stroke risk. Methods-A systematic review and meta-analysis was performed to determine the prognostic value of ES in different potential cerebral embolic sources. Studies were identified that used transcranial Doppler to detect ES and included prospective stroke/TIA follow-up. Numbers of ES-positive and ES-negative patients were extracted with stroke/TIA and stroke alone outcomes. 
D
iagnosis of embolic stroke is usually made by identifying a potential embolic source in a patient with stroke, ie, by guilt by association. Only occasionally can emboli be seen either in the retina or on brain imaging. Using transcranial Doppler, it is possible to detect asymptomatic circulating cerebral emboli. This technique has potential applications in diagnosis, localization of the embolic source, and most importantly, in prediction of risk.
Emboli back scatter and reflect more of ultrasound than surrounding red blood cells. They appear as high-intensity signals, which are of short duration as they rapidly pass through the sample volume. Studies in animal and laboratory models have shown the technique has a high sensitivity and specificity for detection of a variety of embolic materials including thrombus, platelet aggregates, and atheroma. [1] [2] [3] Embolic signals (ES) have been detected in patients with a wide variety of potential embolic sources (Table) . TIA is a strong predictor of recurrent stroke risk and is usually believed to be caused by emboli. By analogy one might expect asymptomatic ES to predict risk. This has led to the technique being increasingly used to direct patient management, and as a surrogate marker of antithrombotic drug efficacy. 4 However, before this it is essential to show that ES do predict future stroke risk. This needs to be demonstrated individually for different potential embolic sources; it is possible that the presence of ES may have different clinical significance in different conditions.
We performed a systematic review and meta-analysis to identify whether ES are independent predictors of future stroke and TIA risk for different potential cerebral embolic sources.
Materials and Methods
Studies containing information on the relationship between ES and future stroke and TIA risk were identified by a defined search strategy. Only prospective studies were included.
Search Strategy
MEDLINE, EMBASE, and PubMed were searched between January 1, 1990 and July 15, 2009. Limits were articles on humans and in English. Search terms were "transcranial Doppler" or "transcranial Doppler" or "ultrasound" or "ultrasonography" and "embolic signals" or "HITS" or "emboli" or "cerebral embolism" or "embolic particles" or "MES" or "microembolic signals" and "stroke" or "transient ischemic attack" or "transient ischaemic attack" or "amaurosis fugax" or "death." Reference lists of articles fulfilling the inclusion criteria and reviews were hand-searched.
Articles were excluded if they:
1. Did not provide data on future stroke/TIA events 2. Used transcranial Doppler-detected ES to guide administration/dosage of drugs to reduce ES 3. Were retrospective 4. Provided insufficient data to construct 2ϫ2 contingency tables 5. Were case reports or series including Ͻ5 subjects
Data Extraction and Management
Studies meeting the inclusion criteria were assessed by 2 researchers. In the event of divergent analysis, a consensus was achieved by discussion. If appropriate data were available for a subset of patients in an article, this subset was included. For duplicate data, the article with the greatest number of subjects was included. Studies were split into subgroups according to potential embolic source. The numbers of ES-positive and ES-negative patients were extracted for 2 outcomes, stroke or TIA and stroke alone. For patients after CEA, when ES frequency can be very high, analysis was also performed according to high vs low rates of ES. When ϩϩ indicates data from Ͼ1 study; ϩ, data from 1 study; -, no data reported.
stroke alone data were not specified, corresponding authors were contacted.
Data Synthesis and Statistical Analysis
Subgroup analysis and investigation of heterogeneity was performed. 
Findings
The prespecified search strategy retrieved 1674 abstract articles from Pub Med (1133), Medline (278), and EMBASE (263). Sixty studies were identified on abstract screening and, after reading full-text articles, 30 of these studies met all inclusion criteria and were included in the meta-analysis. Studies reported the detection of ES in patients with a wide variety of potential embolic sources (Table) . However, for many conditions data were only from cross-sectional studies, and prospective studies relating the presence of ES to future risk were available in only a number of conditions, namely acute stroke and TIA, symptomatic carotid stenosis, asymptomatic carotid stenosis, and CEA. Forest plots summarizing the meta-analyses for these conditions are shown in Figures 1 and 2 .
Results

Acute Stroke and TIA
ES have been detected in between 9.3% and 71% of patients in the acute phase after TIA and stroke [5] [6] [7] [8] [9] [10] [11] [12] (and supplemental refs s2-s10). Studies have consistently shown they are most frequent in patients with large artery disease, less frequent in those with cardioembolic stroke, and infrequent or absent in patients with lacunar stroke 3,10,11 (and supplemental refs s5-s8, s11-s13).
Eight studies (nϭ737) were identified for the acute stroke subgroup. [5] [6] [7] [8] [9] [10] [11] [12] Monitoring was performed from the middle cerebral artery for 20 minutes in 2 studies, 30 minutes in 2, and 60 minutes in 4. Six of the studies limited themselves to anterior circulation stroke alone, 5,7,8,10 -12 whereas 2 included all ischemic stroke. 6, 9 The presence of ES predicted risk of both stroke alone (OR, 2.44; 95% CI, 1.17-5.08; Pϭ0.02; heterogeneity 0.25) and the combined end point of stroke/TIA (OR, 3.71; 95% CI, 1.64 -8.38; Pϭ0.002; heterogeneity Pϭ0.07).
Large Vessel Disease Symptomatic Carotid Stenosis
Many studies have detected ES in patients with symptomatic carotid stenosis; ES has been detected in Ϸ40% of patients if recordings are made for 1 hour. Their presence correlates with known markers of increased risk including: recent symptoms 13 (and supplemental refs s14 -s17), ulcerated plaques (supplemental refs s16, s18 -s20), and stenosis 14 (and supplemental refs s2, s20 -s23), and is reduced in cases of near occlusion with distal collapse (supplemental ref s23).
Four studies (nϭ270) were identified that met the inclusion criteria. 5, 12, 13, 15 
Asymptomatic Carotid Stenosis
ES are less frequent in asymptomatic than symptomatic carotid stenosis 3, 16, 17, 14 (and supplemental refs s1, s17-s18, s22, s24). Five prospective studies (nϭ677) were identified meeting inclusion criteria. 14,16 -19 
Cervical Artery Dissection
A single small study 20 in 28 subjects suggested ES (detected in 46%) may be predictive of early ischemic recurrence in acute internal carotid artery dissection.
Perioperative Period During CEA
ES have been detected at all stages during CEA. It is unclear whether those occurring after arterial opening and before vessel closure are attributable to air emboli accidently introduced or attributable to solid emboli. The former, although having lesser clinical significance, produce more intense signals because of greater reflection and backscattering of ultrasound at the air-blood interface. However, ES occurring during the dissection phase (ie, before arterial opening) and after skin closure are believed to be attributable to solid ES and have been suggested as potential risk markers.
Five studies (nϭ779) were identified that correlated outcome with monitoring during the dissection phase. 21 
Cardioembolic Sources
ES have been reported in patients with a wide variety of cardioembolic sources. With the exception of mechanical prosthetic valves their frequency is lower than in those in patients with symptomatic large artery disease 3 (and supplemental refs s8, s11, s13).
Only 2 studies were identified that met criteria for cardioembolic stroke (supplemental refs s26, s27). The first study was of myocardial infarction, the second was of patients with aortic atherosclerosis who underwent coronary artery bypass grafting. Both reported that stroke was significantly more frequent in patients with ES.
A number of studies reported very high ES frequencies in patients with mechanical prosthetic cardiac valves, but few or no ES with bioprosthetic cardiac valves. 3 (and supplemental refs s11, s31-s34). We found no data on whether ES predict stroke risk.
Discussion
This review found ES had been detected in a wide variety of potential embolic sources, consistent with embolism playing a pathogenic role in many stroke subtypes. However, there was only good-quality data relating the presence of ES to future stroke risk in a few disease groups, namely large artery disease, acute stroke, and the immediate postoperative period after CEA.
Emboli resulting from different embolic sources have different composition and respond differently to treatment. For example, anticoagulants are more effective for cardioembolic stroke, whereas antiplatelet agents appear more effective for emboli from large artery atherosclerotic plaques. For this reason, it is important that the prognostic significance of ES is determined separately for different potential embolic sources. This review found data consistent with ES in different conditions having differing clinical significance.
ES have been consistently detected in some patients with acute ischemic stroke, and in this group are more frequent in the large artery stroke subtype, less frequent in cardioembolic stroke, and absent or rare in lacunar stroke. On meta-analysis significant associations were found with both future stroke and stroke/TIA. This association appeared to be largely attributable to the relationship within the subgroup of patients with large vessel stroke.
In symptomatic carotid stenosis, studies have consistently shown an association between ES and future stroke and TIA risk. Meta-analysis confirmed a highly significant association, although the majority of patients (more than two-thirds) were obtained from 1 study. 15 Further evidence supporting this association comes from the multicenter CARESS trial 4 in which an association was found between baseline ES frequency and 7-day stroke/TIA risk. Patients were only included if they had ES at baseline; therefore, these results could not be incorporated in our meta-analysis. Another intervention study provided further evidence for a causal relationship with stroke risk. ES-positive patients, who then become ES-negative after treatment with aspirin, had a similarly low risk compared to patients who were ESnegative at baseline (supplemental ref s32). Therefore, there is considerable evidence of ES to predict stroke risk. Importantly, it has been shown on multivariate analysis that ES independently predict risk to a greater degree than conventional markers, such as time from symptoms and stenosis. 15 (and supplemental ref s32). Associations have been examined and demonstrated primarily with short-term recurrent stroke risk after acute stroke and symptomatic carotid stenosis.
Despite the strong associations between ES and stroke risk in acute stroke and carotid stenosis, the technique has not gained widespread clinical use. Reasons for this may include the lack of large, multicenter, prospective studies determining prognostic significance, the expertise required to analyze and interpret recordings, and the lack of reliable automated systems for ES detection.
In asymptomatic carotid stenosis, meta-analysis demonstrated an association but with heterogeneity in the analysis of future stroke/TIA risk. This reflects conflicting results of the 2 large studies in this area. These studies had important methodological differences, including one with a single baseline recording, whereas the second repeated recordings at 6 monthly intervals. Further studies are required in this area, and the International Asymptomatic Carotid Emboli Study, 32 which has recruited 482 patients, will finish follow-up in late 2009 and results are expected in 2010.
Transcranial Doppler is widely used to detect ES during and immediately after CEA. After arterial opening, air is introduced. Small air bubbles, despite resulting in highintensity ES, have limited clinical significance, but are impossible to differentiate from potentially more serious solid ES using current transcranial Doppler systems. 33 Not surprisingly, associations have only been detected in situations when gaseous ES are not present, namely the dissection phase (before arterial opening) and the postoperative phase (after arterial closure). During both phases a high rate of ES predicted stroke risk and was more strongly associated than the presence or absence of ES. These data support the use of ES monitoring in this clinical setting.
In contrast to the data relating large artery disease to future risk, there are limited data in cardioembolic stroke but that data available suggest ES are less frequent. In atrial fibrillation, ES were only detected in Յ10% of patients (supplemental ref s35), there was variability between results of recordings performed on different days, although ES did appear less frequent in patients treated with anticoagulation (supplemental ref s36).
One cardioembolic source in which high ES frequencies have been reported is mechanical cardiac valves, with frequencies as high as Ͼ100 per hour (supplemental ref s34). The parallel between this high ES frequency and the high clinical stroke risk suggested a possible prognostic value. However, ES were found to be more intense than expected from thrombus (supplemental ref s12), and ES frequency was not altered by anticoagulation, 3 (and supplemental refs s11, s13, s28, s37), suggesting that they might not represent thromboembolic material. Further studies showed ES frequency was reduced by altering atmospheric pressure in a barometric chamber (supplemental refs s38, s39), or by increasing inspired oxygen concentration (supplemental refs s29, s40 -s42), consistent with this representing gaseous bubbles, perhaps resulting from cavitation at the valve surface. This emphasizes the fact that ES may have different implications in patients with different embolic sources. A recent study (supplemental ref s43) used a novel method of trying to separate solid from gaseous ES and suggested "solid" ES might predict risk in this group, although most recurrent events were TIA and there was only 1 stroke during follow-up. Furthermore, it has been suggested that the technique used for differentiation of solid ES is not reliable. 33 In summary, this review provides strong evidence that ES predicts future ipsilateral stroke risk in patients with large artery disease, particularly symptomatic carotid stenosis. A high frequency also is a strong risk predictor in the immediate postoperative period after CEA and during the dissection phase of CEA. Data are promising in asymptomatic carotid stenosis, although further studies are required. In other conditions, further prospective data are required.
